Filings: Chinese AI startups Zhipu and MiniMax report 2024 revenue of $44.4M and $30.5M, respectively, as both prepare for Hong Kong IPOs in the coming weeks
Chinese OpenAI contenders MiniMax and Zhipu AI offered the first look into their business models and profit prospects in listing filings …
Context & Ripple Effects
MiniMax and Zhipu emerged alongside other Chinese generative-AI startups that had recently attracted multibillion-dollar valuations, making their filings an early test of how private AI narratives translate into disclosed operating businesses.
For MiniMax, the revenue disclosure sits on an IPO path previously signaled by its confidential Hong Kong filing and later followed by a stated Hong Kong IPO fundraising range. The filings give prospective public-market investors a common basis for comparing two prominent contenders.
First-order effects
- MiniMax and Zhipu must now have their 2024 revenue figures assessed alongside their stated profit prospects as they approach public listings.
- The disclosures give IPO investors a direct scale comparison: Zhipu reported higher 2024 revenue than MiniMax, while both become more accountable to public-market scrutiny.
Second-order effects
- Other Chinese AI startups seeking capital face a clearer disclosure benchmark, shifting attention from private valuations toward reported revenue and paths to profitability.
- Hong Kong IPO demand for these companies is likely to hinge more directly on whether investors view their revenue growth as sufficient to support continued AI investment and commercialization.
Third-order effects
- If more AI developers list with comparable disclosures, public markets could become a stronger mechanism for separating companies with demonstrable commercial traction from those supported primarily by private funding narratives.
- The pattern points toward AI infrastructure finance becoming tied more closely to recurring revenue, profit prospects, and listing-market discipline rather than valuation alone.
The trend: Chinese generative-AI developers are moving from private valuation competition toward public-market tests of revenue scale and sustainable commercialization.